- Tytuł:
-
Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus
tenofovir /emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial. - Autorzy:
- Źródło:
- PloS one [PLoS One] 2018 Oct 23; Vol. 13 (10), pp. e0205368. Date of Electronic Publication: 2018 Oct 23 (Print Publication: 2018).
- Typ publikacji:
- Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Anti-HIV Agents/*therapeutic use
Emtricitabine/*therapeutic use
HIV Infections/*drug therapyTenofovir /*therapeutic use
Triterpenes/*therapeutic use
Adult ; Alkynes ; Anti-HIV Agents/pharmacokinetics ; Benzoxazines/pharmacokinetics ; Benzoxazines/therapeutic use ; Cyclopropanes ; Double-Blind Method ; Drug Administration Schedule ; Drug Resistance, Viral ; Drug Therapy, Combination ; Emtricitabine/pharmacokinetics ; Female ; HIV-1/genetics ; HIV-1/isolation & purification ; Half-Life ; Humans ; Male ; Middle Aged ; RNA, Viral/blood ;Tenofovir /pharmacokinetics ; Treatment Outcome ; Triterpenes/pharmacokinetics
Czasopismo naukowe